手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按作者
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
6条
与
K. T.
有关的结果
A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia
2022年 发布于
PLoS One
17卷 第4期
Chughtai
B. Rojanasarot
S. Neeser
K. Gultyaev
D. Fu
S. Bhattacharyya
S. K. El-Arabi
A. M. Cutone
B. J. McVary
K. T.
Aged
Cost-Benefit Analysis
Humans
Male
Medicare
Middle Aged
*Prostatic Hyperplasia/complications
Quality of Life
*Transurethral Resection of Prostate
Treatment Outcome
United States
文献简介
原文链接
Prostate cancer specific mortality after 5α-reductase inhibitors medication in benign prostatic hyperplasia patients: systematic review and meta-analysis
2021年 发布于
Aging Male
24卷 第1期
Park
J. J. Lee
H. Y. Shim
S. R. Lee
S. W. Kim
K. T.
Kim
J. H.
5-alpha Reductase Inhibitors
Humans
Male
Oxidoreductases
Prospective Studies
*Prostatic Hyperplasia/drug therapy
*Prostatic Neoplasms/drug therapy
5?-reductase inhibitors
Bph
Prostate cancer
cancer specific mortality
meta-analysis
文献简介
原文链接
Surgical Reintervention Rate after Prostatic Urethral Lift: Systematic Review and Meta-Analysis Involving over 2,000 Patients
2020年 发布于
J Urol
204卷 第5期
Miller
L. E. Chughtai
B. Dornbier
R. A. McVary
K. T.
Device Removal/statistics & numerical data
Humans
Male
Minimally Invasive Surgical Procedures/*adverse effects/instrumentation
Prostatic Hyperplasia/complications/surgery
Prostatism/etiology
*Prosthesis Failure
Randomized Controlled Trials as Topic
Reoperation/*statistics & numerical data
Transurethral Resection of Prostate/statistics & numerical data
Treatment Outcome
meta-analysis
prostatic hyperplasia
urologic surgical procedures
文献简介
原文链接
Apolipoprotein A1 as a novel urinary biomarker for diagnosis of bladder cancer: A systematic review and meta-analysis
2021 年 发布于
Zentralbl Chir
41 卷 第 1 期
Dardeer
K. T.
Mohammed K. A.
Hussein T. D.
Elsheemy M. S.
Cystectomy/*methods
Female
Humans
Male
Observational Studies as Topic
Robotic Surgical Procedures/*methods
Urinary Bladder Neoplasms/surgery
Urinary Diversion/*methods
文献简介
原文链接
Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review
2020 年 发布于
Frontiers in Oncology
2 卷 第 1 期
Boström P. J.
Jensen J. B.
Jerlström T.
Arum C. J.
Gudjonsson S.
Ettala O.
Syvänen
K. T.
*Cystectomy/adverse effects/methods
Humans
Neoplasm Staging
Neoplasm
Residual/pathology/surgery
*Reoperation/methods/statistics & numerical data
*Urinary Bladder Neoplasms/pathology/surgery
Cystoscopy
Meta-analysis
Neoplasm recurrence
Urinary bladder neoplasms
文献简介
原文链接
Is There an Association Between Ambient Air Pollution and Bladder Cancer Incidence? Analysis of 15 European Cohorts
2018 年 发布于
Diabetes Res Clin Pract
36 卷 第 9 期
Pedersen M.
Stafoggia M.
Weinmayr G.
Andersen Z. J.
Galassi C.
Sommar J.
Forsberg B.
Olsson D.
Oftedal B.
Krog N. H.
Aamodt G.
Pyko A.
Pershagen G.
Korek M.
De Faire U.
Pedersen N. L.
Östenson C. G.
Fratiglioni L.
Sørensen M.
Eriksen
K. T.
Tjønneland A.
Peeters P. H.
Bueno-de-Mesquita B.
Vermeulen R.
Eeftens M.
Plusquin M.
Key T. J.
Jaensch A.
Nagel G.
Concin H.
Wang M.
Tsai M. Y.
Grioni S.
Marcon A.
Krogh V.
Ricceri F.
Sacerdote C.
Ranzi A.
Cesaroni G.
Forastiere F.
Tamayo I.
Amiano P.
Dorronsoro M.
Stayner L. T.
Kogevinas M.
Nieuwenhuijsen M. J.
Sokhi R.
de Hoogh K.
Beelen R.
Vineis P.
Brunekreef B.
Hoek G.
Raaschou-Nielsen O.
Adult
Aged
Aged
80 and over
Antibodies
Monoclonal/therapeutic use
Antibodies
Monoclonal
Humanized/therapeutic use
B7-H1 Antigen/*antagonists & inhibitors/genetics
CTLA-4 Antigen/*antagonists & inhibitors/genetics
Clinical Trials as Topic
Female
Genes
cdc/drug effects
Humans
Ipilimumab
Male
Middle Aged
Neoplasm Metastasis/*drug therapy/genetics/pathology
Nivolumab
Urinary Bladder Neoplasms/*drug therapy/genetics/pathology
Bladder cancer immunotherapy
Checkpoint inhibitor
Pembrolizumab
文献简介
原文链接